Private Li-Fraumeni Syndrome (p53-related cancer predisposition) - TP53 sequencing + MLPA Test in the City of London

Tumour markers are substances produced by the body in response to certain conditions, including some types of cancer. They can be measured in blood to assist in health monitoring.

It is important to understand that tumour marker levels can be elevated for a variety of reasons, many of which are not related to cancer. These tests are not diagnostic on their own and should always be interpreted by a qualified clinician in the context of your overall health.

What the Li-Fraumeni Syndrome (p53-related cancer predisposition) - TP53 sequencing + MLPA Measures

• Specific tumour marker levels in the blood
• Results are compared against standard laboratory reference ranges

When This Test May Be Helpful

• Monitoring a known condition under clinical supervision
• As part of a broader health assessment discussed with your clinician
• Baseline measurement for future comparison
• Family history of specific conditions (discuss with your GP first)

Understanding Your Results

Results are typically available within 6 weeks" and are delivered securely.

Tumour marker levels can be influenced by a wide range of factors, including inflammation, infection, benign conditions, and normal physiological variation. An elevated result does not mean cancer is present, and a normal result does not guarantee the absence of cancer.

We strongly recommend discussing tumour marker results with your GP or the clinician who recommended the test. They can interpret your results in the appropriate clinical context and advise on any further steps.